株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

EpiCast Report:膀胱癌の疫学予測

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025

発行 GlobalData 商品コード 290456
出版日 ページ情報 英文 40 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.28円で換算しております。
Back to Top
EpiCast Report:膀胱癌の疫学予測 EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025
出版日: 2016年12月02日 ページ情報: 英文 40 Pages
概要

膀胱癌の世界における発生数は、毎年1200万件を超え、癌の中でも9番目に多い癌であると推定されています。主要6カ国(米国、フランス、ドイツ、イタリア、スペイン、英国)での発生数は2012年の16万3000件から2022年には19万9000件に達すると予測されており、5年間の患者数は年平均成長率2.22%で増加するものと予測されています。

当レポートは、WHO,IARC,NCIなどが発行している国別データに基づき、世界の主要6ヶ国における膀胱癌について、年齢、性別、病期別の有病率について予測を行っており、危険因子の概要と世界の動向、疫学予測、疫学レポート、疾患動向の分析を提供して、概略以下の構成でお届けいたします。

第1章 目次

第2章 イントロダクション

第3章 疫学

  • 疾患の背景
  • 危険因子と併存疾患
    • 喫煙はもっとも重大な危険因子
    • 男性膀胱癌患者の25%は、業務における芳香族アミンへの暴露によるもの
  • 世界の動向
    • 発生件数、死亡率、5年間の発生率
    • 相対生存率
    • 障害調整生存年数(DALY)、損失生存年数(YLL)
  • 予測手法
    • 利用した情報源
    • 利用しなかった情報源
    • 予測の前提条件と手法
  • 膀胱癌の疫学予測
    • 膀胱版の発生数
    • 発生数:年齢別
    • 発生数:性別
    • 発生率:年齢標準化
    • 発生数:診断ステージ別
    • 5年間の患者数
  • 議論
    • 疫学予測に関する考察
    • 分析の限界
    • 分析の強み

第4章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHCER140-16

Bladder cancer is a commonly diagnosed cancer and causes significant numbers of cancer deaths worldwide (Parkin, 2008; Ploeg et al., 2009). The major risk factors for bladder cancer are exposure to smoking and occupational risk factors such as exposure to aromatic amines. These risk factors are more prevalent among men, which makes the disease significantly more common in men than women (Ploeg et al., 2009). The majority of bladder cancer cases are among older individuals, with the median age at diagnosis being 73 years; because of this, the comorbidities associated with bladder cancer are similar to conditions typically occurring in older age, and therefore are not specific to bladder cancer (Prout et al., 2005).

By 2025, the 7MM are expected to have 289,623 diagnosed incident cases of bladder cancer, representing a 23.5% increase from the number of incident cases in 2015 (234,581 incident cases). In 2015, the 7MM had 873,493 five-year diagnosed prevalent cases of bladder cancer and epidemiologists forecast that by 2025, this number will grow to 1,094,707 five-year diagnosed prevalent cases at an Annual Growth Rate (AGR) of 2.53%.

This forecast is supported by at least 10 years of historical data obtained from country-specific studies published by the World Health Organization's (WHO) International Agency for Research on Cancer (IARC), the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) program, the European Cancer Registry's fifth database registry (EUROCARE-5), the Center for Cancer Control and Information Services, National Cancer Center (CCCIS, NCC) in Japan, as well as country-specific cancer registries. The IARC's Cancer Incidence in Five Continents (CI5)plus data are the gold standard for country-level comparative analysis and were used to provide detailed case segmentation for each country by age and sex.

The report “EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025” provide an overview of the risk factors and global trends of bladder cancer in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of bladder cancer segmented by sex, age (beginning at 15 years and ending at =75 years), and cancer stage at diagnosis (Ta, Tis, T1, T2, T3, and T4), in addition to five-year diagnosed prevalent cases in these seven markets.

Table of Contents

1 Table of Contents 4

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Epidemiology 7

  • 2.1 Disease Background 7
  • 2.2 Risk Factors and Comorbidities 7
  • 2.3 Global Trends 8
    • 2.3.1 Incidence 9
    • 2.3.2 Relative Survival 11
  • 2.4 Forecast Methodology 12
    • 2.4.1 Sources Used Tables 12
    • 2.4.2 Forecast Assumptions and Methods 16
    • 2.4.3 Sources Not Used 20
  • 2.5 Epidemiological Forecast for Bladder Cancer (2015-2025) 21
    • 2.5.1 Diagnosed Incident Cases of Bladder Cancer 21
    • 2.5.2 Age-Specific Diagnosed Incident Cases of Bladder Cancer 22
    • 2.5.3 Sex-Specific Diagnosed Incident Cases of Bladder Cancer 24
    • 2.5.4 Age-Standardized Diagnosed Incidence Rates of Bladder Cancer 26
    • 2.5.5 Diagnosed Incident Cases of Bladder Cancer by Stage at Diagnosis 27
    • 2.5.6 Five-Year Diagnosed Prevalent Cases of Bladder Cancer 27
  • 2.6 Discussion 29
    • 2.6.1 Epidemiological Forecast Insight 29
    • 2.6.2 Limitations of the Analysis 30
    • 2.6.3 Strengths of the Analysis 31

3 Appendix 32

  • 3.1 Bibliography 32
  • 3.2 About the Authors 36
    • 3.2.1 Epidemiologists 36
    • 3.2.2 Reviewer 36
    • 3.2.3 Global Director of Therapy Analysis and Epidemiology 37
  • 3.3 About GlobalData 38
  • 3.4 About EpiCast 38
  • 3.5 Disclaimer 39

List of Tables

  • Table 1: Bladder Cancer Risk Factors 8
  • Table 2: 5EU, Relative Survival of Bladder Cancer (%), Men and Women 12
  • Table 3: 7MM, Sources of Bladder Cancer Incidence Data 13
  • Table 4: 7MM, Sources of Bladder Cancer Stage at Diagnosis Data 14
  • Table 5: 7MM, Sources of Bladder Cancer Relative Survival Data 15
  • Table 6: 7MM, Diagnosed Incident Cases of Bladder Cancer, Ages ≥15 Years, Both Sexes, N, Select Years 2015-2025 21
  • Table 7: 7MM, Age-Specific Diagnosed Incident Cases of Bladder Cancer, Ages ≥15 Years, Both Sexes, N (Row %), 2015 23
  • Table 8: 7MM, Sex-Specific Diagnosed Incident Cases of Bladder Cancer, Ages ≥15 Years, N (Row %), 2015 25
  • Table 9: 7MM, Incident Cases of Bladder Cancer by Stage at Diagnosis, Ages ≥15 Years, Men and Women, N (Row %), 2015 27
  • Table 10: 7MM, Five-Year Diagnosed Prevalent Cases of Bladder Cancer, Ages ≥15 Years, Both Sexes, N, Select Years 2015-2025 28

List of Figures

  • Figure 1: 7MM, Age-Adjusted Diagnosed Incidence Rates of Bladder Cancer (Cases per 100,000 Population), Ages ≥15 Years, Men, 1998-2007 10
  • Figure 2: 7MM, Incidence Rates of Bladder Cancer (Cases per 100,000 Population), Ages ≥15 Years, Women, 1998-2007 11
  • Figure 3: 7MM, Diagnosed Incident Cases of Bladder Cancer, Ages ≥15 Years, Both Sexes, N, Select Years 2015-2025 22
  • Figure 4: 7MM, Age-Specific Diagnosed Incident Cases of Bladder Cancer, Ages ≥15 Years, Both Sexes, N, 2015 24
  • Figure 5: 7MM, Sex-Specific Diagnosed Incident Cases of Bladder Cancer, Ages ≥15 Years, N, 2015 25
  • Figure 6: 7MM, Age-Standardized Diagnosed Incidence of Bladder Cancer (Cases per 100,000 Population), Ages ≥15 Years, Both Sexes, 2015 26
  • Figure 7: 7MM, Five-Year Diagnosed Prevalent Cases of Bladder Cancer, Ages ≥15 Years, Both Sexes, N, 2015-2025 28
Back to Top